Prognostic factors in cutaneous T-cell lymphoma

R Willemze

doi:10.4081/hmr.v2i13.500

Abstracts

10 June 2009

Vol. 2 No. 13 (2006)

https://doi.org/10.4081/hmr.v2i13.500

Prognostic factors in cutaneous T-cell lymphoma

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

PDF

171

Views

891

Downloads

Authors

R Willemze

support@pagepress.org

The term cutaneous T-cell lymphoma (CTCL) describes a heterogeneous group of neoplasms of skin-homing T cells that show considerable variation in clinical presentation, histological appearance, immunophenotype and prognosis. CTCL represent approximately 75-80% of all primary cutaneous lymphomas, whereas primary cutaneous B-cell lymphomas (CBCL) account for approximately 20-25%.